Zurich, Zurich, Switzerland
Biopharma executive combining scientific depth with commercial and strategic experience, bringing a broad perspective shaped by a nearly 20 years career across academia, consulting and industry. Big passion outside science and industry: General Aviation: Instrument-rated Private Pilot License (PPL). Industry experience: ▪️ Thorough understanding of drug development and commercialization ▪️ Cross-functional experience: Investor Relations, Product Strategy, Medical Affairs, Commercial, Competitive Intelligence, Market Access, R&D and Clinical Development ▪️ International experience at Global and Regional level and across major markets ▪️ Knowledge of major Therapeutic Areas including: Oncology, Hematology, Respiratory, Metabolism Disorders & Diabetes, Immunology, Gastroenterology, Neurology, Ophthalmology and Rare Diseases Scientific credentials: ▪️ Postdoc in Cancer Research at ETH (Switzerland) ▪️ PhD in Molecular Biology from UCL (UK) ▪️ MSc in Biotechnology from Jagiellonian University (Poland) ▪️ 1000+ citations ▪️ 7 papers in peer-reviewed journals Key qualities and attributes: ▪️ Curiosity: the "why?" ▪️ Critical thinking: spontaneously engaging in reflective and independent thinking ▪️ Structure & analysis: strong belief in an informed, evidence-based, data-driven decision making ▪️ Belief that attention to detail and "big picture view" are not mutually exclusive ▪️ Top 3 CliftonStrengths: 1) Analytical, 2) Intellection, 3) Strategic (https://www.gallup.com/cliftonstrengths/en/253715/34-cliftonstrengths-themes.aspx)
▪️ Freelance consulting, member of the Insider Group, an advisory founded on decades of industry experience ▪️ Strategic advisory at Fusiomica, a biotechnology startup focused on utilisation of protein engineering and AI in drug discovery
Drove evolution of Global Medical Affairs into a tumor-aligned model; orchestrated strategic and tactical planning across assets; partnered with Head of Breast Cancer to ensure pull through across the franchise.
Led the Hematology franchise in Europe & Canada, driving successful launch and uptake of Calquence. ▪️Developed strategic priorities for the Hematology franchise, identified gaps, and initiated key regional tactics for the successful launch of Calquence in Europe & Canada ▪️Provided strategic guidance to Country Hematology Medical Teams, fostering cross-country synergies and facilitating best practice sharing ▪️Established relationships with medical experts and societies like EHA and ERIC to enhance company visibility and credibility
Had an instrumental role in building and developing Medical Affairs in Europe, taking it through structural changes, improving effectiveness, while ensuring successful launch of key brands: Imfinzi, Tagrisso, Lynparza. ▪️ Functioned alongside the Head of Oncology EUCAN Medical Affairs as main strategic adviser and thought partner to drive business decision making in support of execution of the oncology portfolio strategy ▪️ Successfully managed multiple project teams and vendors, often without formal authority, achieving 100% on-plan and on-budget execution of the key EU&CAN Medical Affairs projects in 2019-2021
Learned business operations and strategic planning, while supporting decision making as Chief of Staff to the VP, Head of Global Medical Affairs Hematology (Advate, Adynovate, Vonvendi). ▪️ Provided strategic planning, operational and project management support to Global Medical Affairs Hematology Franchise ▪️ Ensured project and budget planning, forecasting and execution; established tracking and reporting ▪️ Organized and facilitated leadership meetings and prepared key senior leadership presentations ▪️ Consistently maintained tactic execution on budget, while overseeing 20+ MM USD ▪️ Developed, implemented and improved capabilities and processes (e.g. metrics and KPIs, finance and budgeting process, congress best practice playbook, MSL excellence work streams) ▪️ Developed templates and guidance for the Global Medical Affairs annual planning ▪️ Liaised with R&D, Commercial and Market Access to ensure cross-functional franchise alignment
Delivered high profile strategic projects across functions (Commercial, Medical Affairs, Market Access, Clinical), therapeutic areas and companies, e.g.: ▪️Evidence strategy in support of uptake of an asset in Dry Eye Disease ▪️Launch plan of the first BCL2 inhibitor in Chronic Lymphocytic Leukemia ▪️Patient journey mapping for an FLT3 inhibitor in Acute Myeloid Leukemia ▪️Clinical and CMC plan for a Non-Hodgkin Lymphoma asset